USPTO serial 79271613
QUIAPEG
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 3, 2020
- Examiner
- CROWLEY, SEAN MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with QUIAPEG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Johnson Walden
Cynthia Johnson Walden Fish & Richardson P.C.P.O. Box 1022Minneapolis, MN 55440-1022UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific and research use, Diagnostic preparations for scientific or research use, namely, reagents for use with a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers | ACTIVE | — |
| 005 | Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease derived from PEGylation technologies; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; pharmaceutical, medical and veterinary substances | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations, reagents and substances, and of diagnostic preparations, reagents and substances derived from PEGylation technologies; PEGylation pharmaceuticals research services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by QuiaPEG Pharmaceuticals AB
- Other trademarks owned by QuiaPEG Pharmaceuticals AB
- Other trademarks owned by QuiaPEG Pharmaceuticals AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named QUIAPEG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 3, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 7, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 12, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 12, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 3, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 3, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 18, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 18, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 29, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 13, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 13, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jul 9, 2020 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jun 19, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 28, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 16, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 15, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 22, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 21, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 5, 2019 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Dec 5, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 4, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 19, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 14, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |